CINtec^® Histology

Be conclusive – diagnose with CINtec^® Histology

The CINtec^® Histology test is the only CE-IVD p16 biomarker for clinical/IVD use in the evaluation of cervical biopsy specimens.

Clinical study excellence

The CERTAIN study is one of the largest immunohistochemistry (IHC) clinical studies conducted in the US.

> Learn more

Objectivity in cervical biopsy interpretation

When CINtec^® Histology is used according to the LAST recommendations:

• Diagnostic sensitivity improves by 11.8% and specificity improves by 9.7% to identify high-grade cervical disease¹
• Diagnostic consistency for high-grade disease of challenging cases by the majority of pathologists improves by 29.5%¹

Be conclusive in diagnosing cervical pre-cancer using CINtec^® Histology

10x magnification

40x magnification

CINtec^® Histology enhances identification of occult lesions that may be missed by H&E or morphologic interpretation alone.

Agreement in diagnosis

The adjunctive use of CINtec^® Histology helps pathologists ensure the right patient is treated without unnecessarily treating more patients.

The majority of pathologists using CINtec^® Histology consistently identify 23% – 30% more high-grade cervical disease whether used on all biopsies or according to the LAST recommendations¹.

Pathologists who use CINtec^® Histology demonstrate improved diagnostic consistency and diagnostic agreement between each other and with expert gynecopathologists¹.

Best-in-class

CINtec^® Histology provides objectivity to diagnostic interpretation that helps all pathologists identify more cervical disease.

19,250 CINtec^® Histology slide interpretations by 70 individual surgical pathologists confirmed ≥99.1% acceptability for staining, morphology and background¹.

You think you know what truth is?

In 100 women with disease:

• When only H&E is used, the majority of pathologists could identify 71 of the disease cases¹
• When CINtec^® Histology is used adjunctively with H&E – the majority of pathologists could identify 94 of the disease cases¹

CINtec^® Histology finds 22.8% more high-grade disease¹. These women can now be treated appropriately.

Use CINtec^® Histology to put the spotlight on disease.